Danazol as a second-line treatment for immune thrombocytopenic purpura

Jacques Zimmer^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	97-98
Number of pages	2
Journal	European Journal of Haematology
Volume	102
Issue number	1
DOIs	https://doi.org/10.1111/ejh.13184
Publication status	Published - Jan 2019

Access to Document

@article{0748a6a8897f4afb8eedc1f44bcb7a44,

title = "Danazol as a second-line treatment for immune thrombocytopenic purpura",

author = "Jacques Zimmer",

year = "2019",

month = jan,

doi = "10.1111/ejh.13184",

language = "English",

volume = "102",

pages = "97--98",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc",

number = "1",

}

TY - JOUR

T1 - Danazol as a second-line treatment for immune thrombocytopenic purpura

AU - Zimmer, Jacques

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85056353987&partnerID=8YFLogxK

U2 - 10.1111/ejh.13184

DO - 10.1111/ejh.13184

M3 - Letter

C2 - 30325539

AN - SCOPUS:85056353987

SN - 0902-4441

VL - 102

SP - 97

EP - 98

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 1

ER -